Envista Stock Forecast
NYSE: NVSTHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 3:36 PM ET
NVST analyst consensus
Consensus (15 analysts)
buy
Avg. price target
$29.69+31.52%
- Strong buy 2
- Buy 6
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 15 Wall Street analysts covering Envista (2026-10-07), 8 rate the stock a buy or strong buy, 7 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $29.69, with a high estimate of $35.00 and a low estimate of $23.00. The average target implies upside of 31.5% from the current price of $22.58.
The spread between the highest and lowest targets is 52.2%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NVST.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 13% |
| Buy | 6 | 40% |
| Hold | 7 | 47% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $23.00 | +1.88% |
| Average target | $29.69 | +31.52% |
| High target | $35.00 | +55.04% |